Literature DB >> 14969046

Joint damage and disability in rheumatoid arthritis: an updated systematic review.

D L Scott1, C Smith, G Kingsley.   

Abstract

Joint damage and disability in rheumatoid arthritis (RA) both increase with disease duration but the nature of their relationship is uncertain. This review updates knowledge of the progression and inter-relationship of joint damage and disability in treated RA and provides a synopsis of the main predictive factors for damage and disability. In early RA 39-73% of patients develop one or more erosions in their hands and wrists by 5 years. In established RA the average annual increase in radiological damage scores is 1.9% maximal damage. After 20 years RA patients have on average 43% of maximum possible damage. These data suggests that joint damage progresses constantly over the first 20 years of RA. The average annual increase in HAQ scores is 0.033 per year (1% of possible maximum disability). In the first years of disease there is a "J-shaped" curve with an initial fall in HAQ scores followed by an increase over the next four years. In cross-sectional studies there is either no correlation or a weak correlation between damage and disability in early RA; this absence of correlation is explained by the "J-shaped" curve of disability with disease duration in early RA. As disease duration increases the correlation between damage and disability becomes more obvious; 9 studies show correlation coefficients between 0.31 and 0.75. The most predictive factors of damage and disability are rheumatoid factor status and disease activity. The validity of our conclusions are limited by the potential indirect link between small joint damage and disability, with large joint damage being a more important predictor, and the presence of ceiling effects on X-rays. In conclusion, joint damage accounts for a substantial proportion of the disability associated with the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14969046

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  49 in total

Review 1.  A cytokine-centric view of the pathogenesis and treatment of autoimmune arthritis.

Authors:  Brian Astry; Erin Harberts; Kamal D Moudgil
Journal:  J Interferon Cytokine Res       Date:  2011-12       Impact factor: 2.607

2.  Articular damage in late rheumatoid arthritis.

Authors:  Emel Eksioglu; Reyhan Tuncay; Eda Gurcay; Ajda Bal; Aytul Cakci
Journal:  Clin Rheumatol       Date:  2006-04-22       Impact factor: 2.980

3.  Clinical trials: Tight control in early RA pays off in the long run.

Authors:  David L Scott; Anna Kowalczyk
Journal:  Nat Rev Rheumatol       Date:  2010-11       Impact factor: 20.543

4.  Exploring the relation between impairment rating by DAS-28 and body function, activity participation, and environmental factors based on ICF hand core set in the patient with rheumatoid arthritis.

Authors:  Elif Gür Kabul; Ummuhan Baş Aslan; Bilge Başakçı Çalık; Murat Taşçı; Veli Çobankara
Journal:  Rheumatol Int       Date:  2018-05-30       Impact factor: 2.631

5.  Spinal GABA-B receptor modulates neutrophil recruitment to the knee joint in zymosan-induced arthritis.

Authors:  Gabriel S Bassi; David do C Malvar; Thiago M Cunha; Fernando Q Cunha; Alexandre Kanashiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-23       Impact factor: 3.000

6.  Statin therapy in rheumatoid arthritis: a cost-effectiveness and value-of-information analysis.

Authors:  Nick Bansback; Roberta Ara; Sue Ward; Aslam Anis; Hyon K Choi
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 7.  Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.

Authors:  Eugene Y Kim; Kamal D Moudgil
Journal:  Cytokine       Date:  2017-04-25       Impact factor: 3.861

8.  Is hand bone mineral density a marker for hand function in patients with established rheumatoid arthritis? The correlation among bone mineral density of the hand, radiological findings and hand function.

Authors:  Beril Dogu; Banu Kuran; Figen Yilmaz; Ahmet Usen; Hulya Sirzai
Journal:  Clin Rheumatol       Date:  2013-04-16       Impact factor: 2.980

9.  The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis.

Authors:  M J Harrison; L M Davies; N J Bansback; M J McCoy; S M M Verstappen; K Watson; D P M Symmons
Journal:  Qual Life Res       Date:  2009-09-24       Impact factor: 4.147

10.  The impact of rheumatoid foot on disability in Colombian patients with rheumatoid arthritis.

Authors:  Adriana Rojas-Villarraga; Javier Bayona; Natalia Zuluaga; Santiago Mejia; Maria-Eugenia Hincapie; Juan-Manuel Anaya
Journal:  BMC Musculoskelet Disord       Date:  2009-06-15       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.